THE BEST STOCK BUY FOR MONDAY: QCOR

From June 4, 2012 to July 7, 2012, barely over a month, the stock price of Questcor Pharmaceuticals (ticker QCOR) steadily increased 30% in an otherwise flat market. Then a single short-seller in its blog made what legitimate Wall Street publications later dismissed as “old and misleading claims.” But of course, because of the calculated timing of the short-seller’s attack, it’s bogus claims got publicized before legitimate, objective firms could prepare and publicize their rejections of the short-seller’s claims. So the stock dropped sharply the next day, as investor panic set in.

The stock gradually but steadily declined for three days, presumably as many investors decided to take profits on the stock’s sharp run-up in the month before. Over the week, the stock gave up most, but not all, of the gains it had made during the previous month. This creates a great buying opportunity. The stock has great growth, and value, and no debt, and is very highly rated by analysts, who predict continued strong growth for many years to come

QCOR FINANCIAL STATISTICS AND INFO FROM YAHOO FINANCE http://finance.yahoo.com/q/ks?s=QCOR+Key+Statistics):

FPE: less than 11.4; PEG: 0.5; Profit Margin: 38.5%; ROE: 60%;

Quarterly Revenue Growth (YOY): 160.5%; Quarterly Earnings Growth (YOY): 243.5%

Analyst Opinions: 7 Strong Buys, 2 Buys

Market Cap: $2.75 Billion; Total Debt: 0

QCOR two year stock price increase: steady climb of 300%; QCOR five-year price increase: 2000%

QCOR ten-year stock price increase, July 8, 2002 to July 7, 2012: 4833.33%

Revenue per Share (TTM): $4.42 (more than 10% current market price of $43.13

Major institutional holders include: FMR, LLC: $357 Million; Blackrock, $185 Million;I

Vanguard Group, $131 Million; Oppenheimer, $75 Million; State Street, $62 Million

Major Mutual Fund Holders Include:

Fidelity Investments [total in three funds, including Fidelity’s Blue Chip Growth Fund}: $400,000 million; Vanguard [total three funds]: $80 million;Oppenheimer, $50 Million; IShares S&P Small Cap 600 Index Fund: $44 million;Baron Small Cap Fund: $34 Million

Total holdings of just these five institutional holders and five mutual fund companies: over $1.3 billion

ADDITIONAL QCOR FINANCIAL STATISTICS AND INFO FROM FIDELITY INVESTMENTS:

Analyst Opinions: 9.7, VERY BULLISH;

Revenue Growth (TTM): 120.5%; EPS Growth (TTM v. Prior TTM): 174.6%;

EPS Growth Projected Next Year Vs. This Year: 42%;

Projected Long Term EPS Growth (next three to five years): 34.33%/year

Closing Stock Price on June 5, 2012: $41.00; Closing Stock Price on July 8, 2012: $58.91

Percentage Increase in Stock Price from June 5, 2012 to July 8, 2012: 30%

Single short-seller attack: Sunday, July 10, 2012 [(QCOR “mentioned cautiously in [short-seller] blog”

Closing Stock Price on July 15, 2012: $43.13

Percentage Drop in QCOR Share Price This Week Based on the Short-seller induced panic: 25.6%

(erasing MOST BUT NOT ALL of the stock’s price increase over the previous month)

Wall Street Firms and Publications ATTACKING the Sunday Hit Piece in the Short-Seller’s Blog include:

Oppenheimer; Merrill Lynch; Zacks; Jeffries (“blog post contains old, misleading claims”); Seeking Alpha (“Questcor Acthar is One Hot Drug,” “Buy Questcor’s Growth Cheaply” and “Questcor: Why Analysts Are Improving Its Ratings”); Motley Fool (“Bad Economic News Won’t Stop These Stocks (short-seller attack on QCOR’s Acthar drug “old and misleading” and “Acthar sales soared in June”) ;

Seeking Alpha Report, June 15, 2012:

”Questcor (QCOR +3.5%) moves higher on positive comments out of its conference call this morning to discuss the commercialization of its rheumatology drug, Acthar. Oppenheimer says its highly encouraged by the not only the drugs prospects, but also the company's ability to execute its strategy, while both Caris and Jefferies say Street estimates don't factor in the drug effectively, and will have to move higher.” (emphasis supplied).

Hi reema, around 101

Hi skreddy76, its looking weak. dont enter yet

Hi SS-JJ, above 103 can see 108

Hi CB can i buy tatasteel at this level

HI CB,

Holding TCS 1300CALL@3 what should be SL and Target?

hello CB
What is the outlook
am holding 5300 ce at 80
can i recover my cost

Can i sell LIC Housing cmp 262 & SL 270 ????????

globus hot 2:30pm 108 and in next 20 mints 118